COPD
One minute to ignite new thinking in COPD
Understanding type 2 inflammation* may help shed light on why some patients continue to exacerbate. Watch this video to learn how.1
Campus
- Tuotteet
- Act-HIB®
- Aldurazyme®
- Apidra®
- Aubagio®
- Beyfortus®
- Cablivi®
- Cerdelga®
- Cerezyme®
- Dupixent®
- Dupixent® CRSwNP
- Dupixent® Asthma
- Efluelda®
- Fabrazyme®
- Imovax Polio®
- Insulin aspart Sanofi®
- Insulin lispro Sanofi®
- Jevtana®
- Kevzara®
- Lantus®
- Lemtrada®
- Myozyme®
- Nexviadyme®
- Praluent®
- Rabies Imovax®
- Stamaril®
- Tetravac®
- Toujeo®
- Triaxis®
- Typhim Vi®
- Tyypin 1 diabetes
- Vaxigrip Tetra®
Campus
- Tuotteet
- Act-HIB®
- Aldurazyme®
- Apidra®
- Aubagio®
- Beyfortus®
- Cablivi®
- Cerdelga®
- Cerezyme®
- Dupixent®
- Dupixent® CRSwNP
- Dupixent® Asthma
- Efluelda®
- Fabrazyme®
- Imovax Polio®
- Insulin aspart Sanofi®
- Insulin lispro Sanofi®
- Jevtana®
- Kevzara®
- Lantus®
- Lemtrada®
- Myozyme®
- Nexviadyme®
- Praluent®
- Rabies Imovax®
- Stamaril®
- Tetravac®
- Toujeo®
- Triaxis®
- Typhim Vi®
- Tyypin 1 diabetes
- Vaxigrip Tetra®